Gangrene and renal failure caused by dihydroergotamine used to treat raised intracranial pressure following head trauma

Acta Anaesthesiologica Scandinavica

Volumn 40, Issue 3, 1996, Pages 389-391

  Gupta, V L ^a   Mjorndal T O ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dihydroergotamine; Gangrene; Intracranial pressure; Ischemia; Kidney failure; Spasm

Indexed keywords

DIHYDROERGOTAMINE;

AGED; ARTICLE; CASE REPORT; DRUG TOXICITY; FEMALE; GANGRENE; HEAD INJURY; HUMAN; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; PRIORITY JOURNAL;

EID: 0029963154     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1996.tb04453.x     Document Type: Article

References (13)

1. Miller JD, Becker DP, Ward JD et al. Significance of intracranial hypertension in severe head injury. J Neurosurg 1977: 47: 503-516.
2. Grande P-O. The effects of dihydroergotamine in patients with head injury and raised intracranial pressure. Intensive Care Med 1989: 15: 523-527.
3. Grande P-O, Asgeirsson B, Nordström C-H. A new potential therapy for treatment of post-traumatic brain oedema based on haemodynamic principles for brain volume regulation. In: Recent advances in neurotraumatology. Nakamura N, Hashimoto T, Yasue M (Eds). Tokyo: Springer-Verlag, 1993: 319-322.
4. Westling H, Jansson L., Jonson B et al. Vasoactive drugs and elastic properties of human arteries in vivo with special reference to the effects of nitroglycerine. Eur Heart J 1984: 5: 609-616.
5. Ekeström S, Liljeqvist L, Nordhus O. Negative effects of dihydroergotamine (Orstanorm) on central nemodynamics and aortocoronary blood flow. Scand J Thorac Cardiovasc Surg 1985: 19: 77-83.
6. Mattson E, Ohlin A, Balkfors B et al. Lower limb vasospasm and renal failure during post-operative thromboprophylaxis. Eur J Surg 1991: 157: 289-292.
7. Cunningham M, Torrenté A de, Ekoé JM et al. Vascular spasm and gangrene during heparin-dihydroergotamine prophylaxis. Br J Surg 1984: 71: 829-831.
8. Seifert KB, Blackshear WM, Cruse CW et al. Bilateral upper extremity ischemia after administration of dihydroergot-amine-heparin for prophylaxis of deep venous thrombosis. J Vasc Surg 1988: 8: 410-414.
9. Shackford SR, Davis JW. Refractory vasospasm occurring in a trauma patient receiving dihydroergotamine and heparin. Crit Care Med 1988: 16: 909-910.
10. Meybier H, Krämer KI, Allenberg JR et al. Nierenarteienspasmen nach thrombosprophylaxe mit Heparin/ DHE. Dtsch MedWochenschr 1986: 111: 1781-1782.
11. Fedotin MS, Hartman C. Ergotamine poisoning producing renal artery spasm. N Engl J Med 1970: 283: 518-520.
12. Grande P-O, Nordström C-H, Asgeirsson B. New alternative treatment of post-traumatic brain oedema. Nordisk Medicin 1994: 109: 157-159.
13. Rall TW, Drugs affecting uterine motility. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P eds. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990: 944-946.